Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization

Oncology Reports

Volumn 20, Issue 4, 2008, Pages 825-843

  Roman, Eric ^a   Meza Zepeda, Leonardo A ^b   Kresse, Stine H ^b   Myklebost, Ola ^b,c   Vasstrand, Endre N ^a   Ibrahim, Salah O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Genetic aberration; Microarray based comparative genomic hybridization; Norway; Squamous cell carcinoma; Sudan

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2D; CYTOKINE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P15; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN S100A; RAF PROTEIN; STAT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME 3P; CHROMOSOME 6P; CHROMOSOME 7P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC RISK; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NORWAY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SUDAN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NORWAY; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SUDAN;

EID: 54949126709     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000080     Document Type: Article

References (49)

1. Reshmi SC, Saunders WS, Kudla DM, Ragin CR and Gollin SM: Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 41: 38-46, 2004,
2. Moore SR, Johnson NW, Pierce AM and Wilson DF: The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6: 65-74, 2000.
3. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J and Whelan S: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18: 4779-4786, 1998.
4. Franceschi S, Bidoli E, Herrero R and Munoz N: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 36: 106-115, 2000.
5. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH and Turek LP: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96: 449-455, 2004.
6. Cancer in Norway 2001. The Cancer Registry of Norway, 2001.
7. Idris AM, Ahmed HM and Malik MO: Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 63: 477-480, 1995.
8. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211, 1998.
9. Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC and Albertson DG: Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242, 2005.
10. Bruder CE, Hirvela C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G, Zhang XX, Evans DG, Wallace AJ, Baser ME, Zucman-Rossi J, Hergersberg M, et al: High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 10: 271-282, 2001.
11. Albertson DG: Profiling breast cancer by array CGH. Breast Cancer Res Treat 78: 289-298, 2003.
12. Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A and Rao PH: Molecular cytogenetic characterization of head and neck squamons cell carcinoma and refinement of 3q amplification, Cancer Res 61: 4506-4513, 2001,
13. Bockmuhl U, Schluns K, Kuchler I, Petersen S and Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157: 369-375, 2000.
14. Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND and Greenman J: Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 89: 864-869, 2003.
15. Cawson R and Eveson J: Oral Pathology and Diagnosis (ed). Gower, London, 1987.
16. Wang J, Meza-Zepeda LA, Kresse SH and Myklebost O: M-CGH: analysing microarray-based CGH experiments. BMC Bioinformatics 5: 74, 2004.
17. Churchill GA: Fundamentais of experimental design for cDNA microarrays: Nat Genet 32: 490-495, 2002.
18. Ibrahim SO, Vasstrand EN, Johannessen AC, Idris AM, Magnusson B, Nilsen R and Lillehaug JR: Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer 81: 527-534, 199.
19. Ibrahim SO, Aarsaether N, Holsve MK, Kross KW, Heimdal JH, Aarstad JH, Liavaag PG, Elgindi OA, Johannessen AC, Lillehaug JR and Vasstrand EN: Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncol 39: 37-48, 2003.
20. Choi P and Chen C: Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 104: 1113-1128, 2005.
21. Jarvinen AK, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grenman R, Leivo I, Kailioniemi O, Makitie AA and Monni O: Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25: 6997-7008, 2006.
22. Nagatsuka H, Siar CH, Nakano K, Tsujigiwa H, Gunduz M, Choufuku H, Lee YJ, Naito I, Sado Y and Nagai N: Differential expression of collagen IV alpha1 to alpha6 chains in basement membranes of benign and malignant odontogenic tumors. Virchows Arch 441: 392-399, 2002.
23. de Vicente JC, Fresno MF, Villalain L, Vega JA and Hernandez Vallejo G: Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41: 283-293, 2005.
24. Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, Doebele M, von Werder A, Fulda C, Nakagawa H, Rustgi AK, Blum HE, et al: Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci USA 102: 15599-15604, 2005.
25. Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36: 311-327, 2000.
26. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P and Joos S: Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45:118-125, 2006.
27. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, et al: Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: 2872-2880, 2003.
28. Bizati L, Borim AA, Leite KR, Goncalves Fde T, Cury PM, Tajara EH and Silva AE: Alterations of the CCND1 and HER-2/ neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet 165: 41-50, 2006.
29. Malara NM, Leotta A, Sidoti A, Lio S, D'Angelo R, Caparello B, Munao F, Pino F and Amato A: Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. Breast 15: 81-89, 2006.
30. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A, Rau B, Radlwimmer B, Dohner H, Lichter P, Gress T and Bentz M: Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 64: 4428-4433, 2004.
31. Ibrahim SO, Lillehaug JR and Vasstrand EN: Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas. Anticancer Res 23: 4593-4600, 2003.
32. Dysvik B, Vasstrand EN, Lovlie R, Elgindi OA, Kross KW, Aarstad HJ, Johannessen AC, Jonassen I and Ibrahim SO: Gene expression profiles of head and neck carcinomas from Sudanese and Norwegian patients reveal common biological pathways regardless of race and lifestyle. Clin Cancer Res 12: 1109-1120, 2006.
33. Emberley ED, Murphy LC and Watson PH: S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82: 508-515, 2004.
34. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS and Barraclough R: Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24: 1445-1454, 2005.
35. Tsai ST, Jin YT, Tsai WC, Wang ST, Lin YC, Chang MT and Wu LW: S100A2, a potential marker for early recurrence in early-stage oral cancer. Oral Oncol 41: 349-357, 2005.
36. Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M, Hochli M and Heizmann CW: The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 280: 29186-29193, 2005.
37. el-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H and Huff V: Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 55: 2656-2659, 1995.
38. Huang X, Gollin SM, Raja S and Godfrey TE: High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99:11369-11374, 2002.
39. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F and Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389, 1997.
40. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
41. Hsu LC, Huang X, Seasholtz S, Potter DM and Gollin SM: Gene amplification and overexpression of protein phosphatase 1 alpha in oral squamous cell carcinoma cell lines. Oncogene 25: 5517-5526, 2006.
42. Baldwin C, Garnis C, Zhang L, Rosin MP and Lana WL: Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567, 2005.
43. Li C, Chen L and Chen J: DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms. Mol Cell Biol 22: 7562-7571, 2002.
44. Danovi D, Meulmeester E, Pasini D, Migliorini D, Capta M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, et al: Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 24: 5835-5843, 2004.
45. Thomas GT, Lewis MP and Speight PM: Matrix metallo-proteinases and oral cancer. Oral Oncol 35: 227-233, 1999.
46. Patel BP, Shah SV, Shukla SN, Shah PM and Patel PS: Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck (In press).
47. Baker EA, Leaper DJ, Hayter JP and Dickenson AJ: The matrix metalloproteinase system in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 44: 482-486, 2006.
48. Zhang Y, Wang C, Mizukami H, Itoh H, Kusama M, Ozawa K and Jinbu Y: Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis. J Exp Clin Cancer Res 25: 417-423, 2006.
49. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namløs HM, Wang J, Kristiansen BE and Myklebost O: Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66: 8984-8993, 2006.